These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 2125080)

  • 1. Prediction of lithium treatment response in bipolar depression using 5-HTT and 5-HT
    Ananth M; Bartlett EA; DeLorenzo C; Lin X; Kunkel L; Vadhan NP; Perlman G; Godstrey M; Holzmacher D; Ogden RT; Parsey RV; Huang C
    Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2417-2428. PubMed ID: 32055965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant drugs in bipolar disorder.
    Grunze H; Schlösser S; Amann B; Walden J
    Dialogues Clin Neurosci; 1999 Jun; 1(1):24-40. PubMed ID: 22033602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lithium treatment enhances the postsynaptic 5-HT1A receptor-mediated 5-HT behavioral syndrome induced by 8-OH-DPAT in rats via catecholaminergic systems.
    Uchitomi Y; Yamawaki S
    Psychopharmacology (Berl); 1993; 112(1):74-9. PubMed ID: 7871012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic treatment with valproate on serotonin-1A receptor binding and function.
    Khaitan L; Calabrese JR; Stockmeier CA
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):539-42. PubMed ID: 7862872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No alterations in the 5-HT1A-mediated inhibition of forskolin-stimulated adenylate cyclase activity in the hippocampal membranes from rats chronically treated with lithium or antidepressants.
    Odagaki Y; Koyama T; Yamashita I
    J Neural Transm Gen Sect; 1991; 86(2):85-96. PubMed ID: 1953990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium treatment regimens induce different changes in [3H]paroxetine binding protein and other rat brain proteins.
    Plenge P; Mellerup ET; Jørgensen OS
    Psychopharmacology (Berl); 1992; 106(1):131-5. PubMed ID: 1310811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic lithium treatment on serotonin binding sites in rat brain.
    Odagaki Y; Koyama T; Matsubara S; Matsubara R; Yamashita I
    J Psychiatr Res; 1990; 24(3):271-7. PubMed ID: 2125080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic effects of imipramine and lithium on postsynaptic 5-HT1A and 5-HT1B sites and on presynaptic 5-HT3 sites in rat brain.
    Mizuta T; Segawa T
    Jpn J Pharmacol; 1988 Jun; 47(2):107-13. PubMed ID: 3199589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic effects of imipramine and lithium on 5-HT receptor subtypes in rat frontal cortex, hippocampus and choroid plexus: quantitative receptor autoradiographic analysis.
    Mizuta T; Segawa T
    Jpn J Pharmacol; 1989 Jul; 50(3):315-26. PubMed ID: 2761132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents.
    Hall MD; Gozlan H; Emerit MB; el Mestikawy S; Pichat L; Hamon M
    Neurochem Res; 1986 Jun; 11(6):891-912. PubMed ID: 3016581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a chronic lithium treatment on cortical serotonin uptake sites and 5-HT1A receptors.
    Carli M; Afkhami-Dastjerdian S; Reader TA
    Neurochem Res; 1997 Apr; 22(4):427-35. PubMed ID: 9130253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.